Back to Index
David Y. Ko, MD
Associate Professor of Clinical Neurology
GNH A4e Off Campus Los Angeles
+1 323 409 7371


Ko D, Yang H, Williams B, Xing D, Laurenza A. Perampanel in the treatment of partial seizures: Time to onset and duration of most common adverse events from pooled Phase III and extension studies. Epilepsy Behav. 2015 Jul; 48:45-52. View in: PubMed

Ko D, Ramsay RE. Perampanel: expanding therapeutic options for patients with medically refractory secondary generalized convulsive seizures. Acta Neurol Scand Suppl. 2013; (197):36-43. View in: PubMed

Rison RA, Ko DY. Isolated fatty liver from prolonged propofol use in a pediatric patient with refractory status epilepticus. Clin Neurol Neurosurg. 2009 Jul; 111(6):558-61. View in: PubMed

Lund BT, Ashikian N, Ta HQ, Chakryan Y, Manoukian K, Groshen S, Gilmore W, Cheema GS, Stohl W, Burnett ME, Ko D, Kachuck NJ, Weiner LP. Increased CXCL8 (IL-8) expression in Multiple Sclerosis. J Neuroimmunol. 2004 Oct; 155(1-2):161-71. View in: PubMed

Ko DY. Clinical evaluation of patients with head trauma. Neuroimaging Clin N Am. 2002 May; 12(2):165-74. View in: PubMed

Powered bySC CTSI